List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 306 studies with search of: pemetrexed
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors
Conditions: Mesothelioma;   Non-small Cell Lung Cancer;   Neoplasms
Intervention: Drug: Sunitinib, Pemetrexed, Cisplatin, Carboplatin
2 Active, not recruiting Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients
Conditions: Non Small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: Vandetanib;   Drug: Pemetrexed
3 Recruiting Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Condition: Advanced Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Pemetrexed plus carboplatin
4 Recruiting Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
Conditions: Malignant Pleural Mesothelioma;   MPM;   Solid Tumors
Interventions: Drug: pemetrexed, cisplatin and CBP501;   Drug: pemetrexed and cisplatin
5 Active, not recruiting A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies
Condition: Neoplasms
Intervention: Drug: Sunitinib, Pemetrexed
6 Recruiting Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: Bevacizumab + Pemetrexed;   Drug: Bevacizumab + Pemetrexed + Carboplatin
7 Completed Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: combination chemotherapy (pemetrexed + cisplatin);   Radiation: thoracic irradiation + pemetrexed
8 Active, not recruiting Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Pemetrexed;   Drug: Dexamethasone
9 Recruiting Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
Condition: Central Nervous System Lymphoma
Intervention: Drug: pemetrexed
10 Recruiting Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Docetaxel;   Biological: cetuximab;   Drug: Pemetrexed
11 Active, not recruiting Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed
12 Active, not recruiting Pemetrexed Plus Gemcitabine in Renal Cell Cancer
Condition: Renal Cell Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine
13 Recruiting Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM
Condition: Mesothelioma
Intervention: Drug: Carboplatin, Bevacizumab and Pemetrexed
14 Recruiting Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pemetrexed/Oxaliplatin
15 Active, not recruiting A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Condition: Head and Neck Cancer
Intervention: Drug: Pemetrexed plus Gemcitabine
16 Recruiting Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Pemetrexed and temsirolimus
17 Completed A Phase I/II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer
Condition: Advanced Non-Small Cell Lung Cancer
Interventions: Drug: Lapatinib;   Drug: Pemetrexed
18 Recruiting Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma
Intervention: Drug: Pemetrexed
19 Recruiting A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: pemetrexed;   Drug: carboplatin
20 Active, not recruiting ZD4054 Phase II Non-Small Cell Lung Cancer Study
Conditions: Non Small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: ZD4054;   Drug: Pemetrexed;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services